Diekman John D
SEC-identified person · CIK 1240357 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Zai Lab Ltd ZLAB | Director | filed 2021–2026 |
| Skye Bioscience, Inc. SKYE | Officer | filed 2023–2025 |
| Thimble Point Acquisition Corp. THMAU | Officer | filed 2021–2023 |
| Scpharmaceuticals Inc. SCPH | Officer | filed 2017–2022 |
| Q32 Bio Inc. QTTB | Officer | filed 2018–2020 |
| Ideaya Biosciences, Inc. IDYA | Director | filed 2019–2020 |
| Aprea Therapeutics, Inc. APRE | Officer | filed 2019–2020 |
| Arvinas, INC. AVRN | Officer | filed 2018–2019 |
| Crinetics Pharmaceuticals, Inc. CRNX | Officer | filed 2018–2019 |
| Audentes Therapeutics, Inc. BOLD | Officer | filed 2016–2017 |
| Phaserx, INC. PZRX | Officer | filed 2016–2016 |
| Viveve Medical, INC. plcsf | Officer | filed 2014–2015 |
| Cidara Therapeutics, Inc. CDTX | Officer | filed 2015–2015 |
| Zalicus Inc. ZLCS | Officer | filed 2014–2015 |
| Affymetrix INC AFFX | Director | filed 2006–2012 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.